A Case Study

IMA Active and Medochemie have joined forces in order to achieve optimal low-dose dry powder inhalers by combining the dosator technology and the direct net weight control both in a table-top device and in an industrial productionscale capsule filler. A study conducted by IMA that investigates optimal process parameters for micro-dose DPIs achieved by the dosator technology. Pietro Pirera at IMA Active describes how maintaining the free-flowing properties of the dispended powder within the capsule better ensures the release of powder from the capsule into the inhaler when the capsule is pierced.